NASDAQ:CUR - Neuralstem Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.07 +0.01 (+0.94 %)
(As of 09/25/2018 03:00 AM ET)
Previous Close$1.08
Today's Range$1.05 - $1.10
52-Week Range$0.88 - $3.09
Volume45,400 shs
Average Volume165,268 shs
Market Capitalization$16.22 million
P/E RatioN/A
Dividend YieldN/A
Beta1.61
Neuralstem logoNeuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Receive CUR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CUR
CUSIPN/A
Phone301-366-4841

Debt

Debt-to-Equity RatioN/A
Current Ratio10.41
Quick Ratio10.41

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$260,000.00
Price / Sales62.39
Cash FlowN/A
Price / CashN/A
Book Value$0.56 per share
Price / Book1.91

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-15,660,000.00
Net Margins-1,401.80%
Return on Equity-75.90%
Return on Assets-48.98%

Miscellaneous

Employees6
Outstanding Shares15,160,000
Market Cap$16.22 million

Neuralstem (NASDAQ:CUR) Frequently Asked Questions

What is Neuralstem's stock symbol?

Neuralstem trades on the NASDAQ under the ticker symbol "CUR."

How were Neuralstem's earnings last quarter?

Neuralstem, Inc. (NASDAQ:CUR) issued its earnings results on Wednesday, August, 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $0.25 million for the quarter. Neuralstem had a negative return on equity of 75.90% and a negative net margin of 1,401.80%. View Neuralstem's Earnings History.

When is Neuralstem's next earnings date?

Neuralstem is scheduled to release their next quarterly earnings announcement on Monday, November, 12th 2018. View Earnings Estimates for Neuralstem.

What price target have analysts set for CUR?

0 Wall Street analysts have issued 12-month price targets for Neuralstem's stock. Their forecasts range from $1.91 to $1.91. On average, they anticipate Neuralstem's stock price to reach $1.91 in the next year. This suggests a possible upside of 78.5% from the stock's current price. View Analyst Price Targets for Neuralstem.

Who are some of Neuralstem's key competitors?

Who are Neuralstem's key executives?

Neuralstem's management team includes the folowing people:
  • Jim Scully, Chief Executive & Accounting Officer
  • Karl Y. Johe, Chief Scientific Officer
  • David Recker, Chief Medical Officer
  • Thomas Hazel, Senior Vice President-Research
  • Kimberly Minarovich, Head-Investor Relations

How do I buy shares of Neuralstem?

Shares of CUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neuralstem's stock price today?

One share of CUR stock can currently be purchased for approximately $1.07.

How big of a company is Neuralstem?

Neuralstem has a market capitalization of $16.22 million and generates $260,000.00 in revenue each year. Neuralstem employs 6 workers across the globe.

What is Neuralstem's official website?

The official website for Neuralstem is http://www.neuralstem.com.

How can I contact Neuralstem?

Neuralstem's mailing address is 20271 Goldenrod Lane, Germantown MD, 20876. The company can be reached via phone at 301-366-4841 or via email at [email protected]


MarketBeat Community Rating for Neuralstem (NASDAQ CUR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  217 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  401
MarketBeat's community ratings are surveys of what our community members think about Neuralstem and other stocks. Vote "Outperform" if you believe CUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel